Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
HTML
Details
Locations
Year:
2020
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2020.1773790
Authors:
Giacomo Sgalla,
Claudia Franciosa,
Jacopo Simonetti,
Luca Richeldi
Institutions:
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
Università Cattolica del Sacro Cuore
Language:
English
Topic:
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Subfield:
Pulmonary and Respiratory Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
idiopathic pulmonary fibrosis,
connective tissue growth factor,
monoclonal antibodies,
pirfenidone,
nintedanib,
combination therapy,
pharmacokinetics,
pharmacodynamics,
intravenous administration,
antifibrotic therapy
show all 10
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W3027885648
FWCI:
1.207
Cites:
40
Cited by:
61
Related to:
10